Adriana Hansen/PitchBook News
Ninety minutes was all it took a federal jury to reject Elon Musk’s claim that OpenAI execs Sam Altman and Greg Brockman “stole a charity” when the AI giant partnered with Microsoft and created a for-profit arm. The jury found that Musk waited too long to sue, which the judge concurred with, clearing a major legal overhang on OpenAI’s anticipated IPO plans.
The trial highlighted a question that will follow OpenAI into the public markets: Will its status as a public benefit corporation—the do-gooder company structure it adopted last October—shape its business pursuits? With OpenAI free to remain a for-profit company with a public benefit goal baked in, a structure rival Anthropic also adopted, upcoming IPO plans will test investors’ appetite for corporate priorities beyond growing the value of their shares.
“A lot of people would say there’s plenty of room to do pro-social things, as long as you can argue with a straight face that doing those pro-social things will ultimately lead to greater profits,” said Michael Dorff, a visiting law professor at UCLA and author of a book on PBCs published in 2023. “It’s very hard to enforce a core mission because of something called the ‘business judgment rule,’ which in essence says that as long as the board is acting in an informed way in good faith, the courts will give you enormous deference. ”
Corporate law in Delaware, where both companies are incorporated, requires a PBC board to balance profits with a stated mission of public benefit. But how that balancing happens and how it gets enforced is left almost entirely up to the board’s discretion, and legal scholars say OpenAI’s stated benefit of “ensuring AGI benefits all of humanity” is broad enough to cover nearly any decision.
“For-profit versus a public benefit corporation—there’s no difference,” said Brian JM Quinn, a professor of corporate law at Boston College Law School.
“Our shareholders are humans, right? Oh, ‘good for humanity!’” he said. “Being a public benefit corporation doesn’t dictate what the result of the balancing will be.”
Only significant shareholders can sue a PBC for breaching this balancing duty under Delaware law. The way OpenAI was restructured leaves little incentive for anyone to challenge the company’s decision-making, according to Dorff. Six of the seven board directors of OpenAI’s nonprofit wing also sit on the for-profit PBC board.
“It doesn’t really mean anything to say that when I’m wearing my hat as a board member of the nonprofit, I’m in control of the for-profit,” he said. “I can put on one hat and tell myself, ‘Don’t do that,’ and put on the other hat and say, ‘But I want to do that.’”
The enforcement vacuum has implications beyond just OpenAI. “It’s the $20 million question: who has the standing to go and challenge it?” said Gregory Emrick, principal attorney in the commercial litigation department at the firm Offit Kurman. “What is their north star, [in] figuring out what the proper thing to do is for the company? Is it to, you know, Google’s old statement ‘don’t be evil,’ or is it to maximize profits? And a capitalist society does not consider those things to be even remotely aligned.”
The company’s main rival, Anthropic, is also reportedly planning an IPO for later this year. Like OpenAI, Anthropic has come under scrutiny for some of its decision-making that has appeared to be at odds with a mission to benefit the public, notably its courting of investors from the Gulf States.
“This is a real downside and I’m not thrilled about it,” CEO Dario Amodei wrote in internal messages, Wired reported. “Unfortunately, I think ‘No bad person should ever benefit from our success’ is a pretty difficult principle to run a business on.”
Anthropic’s own public benefit goal is “responsible development and maintenance of advanced AI for the longer benefit of humanity” — just as vague as OpenAI’s.
The bigger test for the companies’ mission-driven structures is still ahead. OpenAI is reportedly filing confidentially for its IPO as soon as Friday, and Anthropic is expected to not be far behind.
Learn about our editorial standards.